INSM logo

Insmed Incorporated (INSM) EBITDA

Annual EBITDA:

-$818.79M-$158.62M(-24.03%)
December 31, 2024

Summary

  • As of today, INSM annual EBITDA is -$818.79 million, with the most recent change of -$158.62 million (-24.03%) on December 31, 2024.
  • During the last 3 years, INSM annual EBITDA has fallen by -$435.15 million (-113.42%).
  • INSM annual EBITDA is now -780.54% below its all-time high of $120.31 million, reached on December 31, 2009.

Performance

INSM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMincome statement metrics

Quarterly EBITDA:

-$257.36M-$7.23M(-2.89%)
September 30, 2025

Summary

  • As of today, INSM quarterly EBITDA is -$257.36 million, with the most recent change of -$7.23 million (-2.89%) on September 30, 2025.
  • Over the past year, INSM quarterly EBITDA has dropped by -$61.33 million (-31.29%).
  • INSM quarterly EBITDA is now -66258.35% below its all-time high of $389.00 thousand, reached on December 31, 2009.

Performance

INSM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMincome statement metrics

TTM EBITDA:

-$976.65M-$61.33M(-6.70%)
September 30, 2025

Summary

  • As of today, INSM TTM EBITDA is -$976.65 million, with the most recent change of -$61.33 million (-6.70%) on September 30, 2025.
  • Over the past year, INSM TTM EBITDA has dropped by -$283.73 million (-40.95%).
  • INSM TTM EBITDA is now -72351.93% below its all-time high of -$1.35 million, reached on September 30, 2010.

Performance

INSM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

INSM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-24.0%-31.3%-41.0%
3Y3 Years-113.4%-116.9%-143.2%
5Y5 Years-277.2%-383.0%-391.2%

INSM EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-113.4%at low-116.9%at low-143.2%at low
5Y5-Year-277.2%at low-383.0%at low-391.2%at low
All-TimeAll-Time-780.5%at low>-9999.0%at low>-9999.0%at low

INSM EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$257.36M(-2.9%)
-$976.65M(-6.7%)
Jun 2025
-
-$250.13M(-10.3%)
-$915.32M(-8.0%)
Mar 2025
-
-$226.69M(+6.5%)
-$847.70M(-9.3%)
Dec 2024
-$818.79M(-24.0%)
-$242.47M(-23.7%)
-$775.56M(-11.9%)
Sep 2024
-
-$196.03M(-7.4%)
-$692.92M(-9.7%)
Jun 2024
-
-$182.50M(-18.1%)
-$631.68M(+5.0%)
Mar 2024
-
-$154.55M(+3.3%)
-$665.09M(-0.5%)
Dec 2023
-$660.18M(-47.6%)
-$159.83M(-18.6%)
-$661.93M(-1.6%)
Sep 2023
-
-$134.79M(+37.6%)
-$651.27M(-2.5%)
Jun 2023
-
-$215.91M(-42.6%)
-$635.15M(-24.4%)
Mar 2023
-
-$151.39M(-1.5%)
-$510.56M(-12.0%)
Dec 2022
-$447.37M(-16.6%)
-$149.18M(-25.7%)
-$455.70M(-13.5%)
Sep 2022
-
-$118.67M(-29.9%)
-$401.55M(-7.7%)
Jun 2022
-
-$91.32M(+5.4%)
-$372.75M(-3.0%)
Mar 2022
-
-$96.53M(-1.6%)
-$361.74M(-6.3%)
Dec 2021
-$383.65M(-53.2%)
-$95.02M(-5.7%)
-$340.18M(-1.4%)
Sep 2021
-
-$89.88M(-11.9%)
-$335.36M(-12.2%)
Jun 2021
-
-$80.31M(-7.1%)
-$298.76M(-12.8%)
Mar 2021
-
-$74.97M(+16.9%)
-$264.82M(-8.0%)
Dec 2020
-$250.37M(-15.3%)
-$90.20M(-69.3%)
-$245.15M(-23.3%)
Sep 2020
-
-$53.28M(-14.9%)
-$198.85M(+0.5%)
Jun 2020
-
-$46.36M(+16.2%)
-$199.80M(+6.3%)
Mar 2020
-
-$55.31M(-26.0%)
-$213.18M(+5.3%)
Dec 2019
-$217.07M(+26.5%)
-$43.90M(+19.1%)
-$225.06M(+15.6%)
Sep 2019
-
-$54.23M(+9.2%)
-$266.72M(+9.7%)
Jun 2019
-
-$59.74M(+11.1%)
-$295.51M(+4.0%)
Mar 2019
-
-$67.19M(+21.5%)
-$307.72M(-1.7%)
Dec 2018
-$295.18M(-59.7%)
-$85.55M(-3.0%)
-$302.51M(-7.4%)
Sep 2018
-
-$83.03M(-15.4%)
-$281.58M(-16.4%)
Jun 2018
-
-$71.95M(-16.1%)
-$241.92M(-13.7%)
Mar 2018
-
-$61.98M(+4.1%)
-$212.75M(-14.4%)
Dec 2017
-$184.87M(-8.6%)
-$64.62M(-49.0%)
-$186.02M(+0.9%)
Sep 2017
-
-$43.37M(-1.4%)
-$187.77M(-3.8%)
Jun 2017
-
-$42.78M(-21.3%)
-$180.87M(-4.2%)
Mar 2017
-
-$35.25M(+46.9%)
-$173.66M(-1.6%)
Dec 2016
-$170.24M(-47.7%)
-$66.37M(-82.0%)
-$170.96M(-25.2%)
Sep 2016
-
-$36.48M(-2.6%)
-$136.54M(-5.2%)
Jun 2016
-
-$35.56M(-9.3%)
-$129.85M(-6.6%)
Mar 2016
-
-$32.55M(-1.9%)
-$121.79M(-5.4%)
Dec 2015
-$115.28M(-33.9%)
-$31.95M(-7.3%)
-$115.51M(-8.7%)
Sep 2015
-
-$29.78M(-8.3%)
-$106.25M(-6.8%)
Jun 2015
-
-$27.50M(-4.7%)
-$99.52M(-5.1%)
Mar 2015
-
-$26.27M(-15.8%)
-$94.65M(-9.7%)
Dec 2014
-$86.09M(-58.8%)
-$22.69M(+1.6%)
-$86.29M(-9.2%)
Sep 2014
-
-$23.05M(-1.8%)
-$78.99M(-8.8%)
Jun 2014
-
-$22.64M(-26.4%)
-$72.61M(-25.0%)
Mar 2014
-
-$17.91M(-16.4%)
-$58.09M(-6.9%)
Dec 2013
-$54.20M(-35.3%)
-$15.39M(+7.7%)
-$54.33M(+0.5%)
Sep 2013
-
-$16.67M(-105.5%)
-$54.63M(-15.8%)
Jun 2013
-
-$8.11M(+42.7%)
-$47.18M(+3.5%)
Mar 2013
-
-$14.16M(+9.7%)
-$48.91M(-16.8%)
Dec 2012
-$40.05M
-$15.69M(-70.3%)
-$41.88M(-19.8%)
Sep 2012
-
-$9.21M(+6.4%)
-$34.95M(-0.9%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$9.85M(-38.1%)
-$34.62M(+1.6%)
Mar 2012
-
-$7.13M(+18.6%)
-$35.17M(+0.6%)
Dec 2011
-$59.31M(-857.7%)
-$8.76M(+1.5%)
-$35.38M(-25.8%)
Sep 2011
-
-$8.89M(+14.5%)
-$28.13M(-41.8%)
Jun 2011
-
-$10.39M(-41.6%)
-$19.83M(-91.6%)
Mar 2011
-
-$7.34M(-389.0%)
-$10.35M(-219.7%)
Dec 2010
-$6.19M(-105.1%)
-$1.50M(-151.0%)
-$3.24M(-140.2%)
Sep 2010
-
-$598.00K(+34.5%)
-$1.35M(+7.3%)
Jun 2010
-
-$913.00K(-304.0%)
-$1.45M(-0.2%)
Mar 2010
-
-$226.00K(-158.1%)
-$1.45M(+81.8%)
Dec 2009
$120.31M(+1000.0%)
$389.00K(+155.3%)
-$7.97M(+32.8%)
Sep 2009
-
-$704.00K(+22.6%)
-$11.86M(+7.3%)
Jun 2009
-
-$910.00K(+86.5%)
-$12.79M(+20.0%)
Mar 2009
-
-$6.74M(-92.2%)
-$16.00M(-19.7%)
Dec 2008
-$13.37M(+33.3%)
-$3.51M(-114.6%)
-$13.37M(-2.4%)
Sep 2008
-
-$1.64M(+60.2%)
-$13.06M(+15.5%)
Jun 2008
-
-$4.11M(+0.1%)
-$15.45M(-11.8%)
Mar 2008
-
-$4.11M(-28.7%)
-$13.83M(+24.6%)
Dec 2007
-$20.03M(+60.7%)
-$3.20M(+20.7%)
-$18.33M(+36.7%)
Sep 2007
-
-$4.03M(-62.4%)
-$28.96M(+22.9%)
Jun 2007
-
-$2.48M(+71.2%)
-$37.57M(+15.2%)
Mar 2007
-
-$8.62M(+37.7%)
-$44.33M(-1.0%)
Dec 2006
-$51.00M(-250.9%)
-$13.83M(-9.4%)
-$43.90M(-32.7%)
Sep 2006
-
-$12.64M(-36.7%)
-$33.09M(-45.9%)
Jun 2006
-
-$9.24M(-12.8%)
-$22.68M(-19.1%)
Mar 2006
-
-$8.19M(-171.8%)
-$19.04M(-17.9%)
Dec 2005
-$14.54M(+46.9%)
-$3.02M(-35.3%)
-$16.14M(+15.1%)
Sep 2005
-
-$2.23M(+60.2%)
-$19.01M(+22.2%)
Jun 2005
-
-$5.60M(-5.8%)
-$24.42M(+12.4%)
Mar 2005
-
-$5.30M(+9.9%)
-$27.87M(-1.7%)
Dec 2004
-$27.39M(-161.1%)
-$5.88M(+23.0%)
-$27.39M(-14.1%)
Sep 2004
-
-$7.64M(+15.6%)
-$24.00M(-27.6%)
Jun 2004
-
-$9.05M(-87.7%)
-$18.80M(-44.2%)
Mar 2004
-
-$4.82M(-93.7%)
-$13.04M(-24.3%)
Dec 2003
-$10.49M(+69.3%)
-$2.49M(-1.8%)
-$10.49M(+6.5%)
Sep 2003
-
-$2.44M(+25.6%)
-$11.22M(-2.4%)
Jun 2003
-
-$3.29M(-44.6%)
-$10.96M(+26.1%)
Mar 2003
-
-$2.27M(+29.4%)
-$14.84M(+20.9%)
Dec 2002
-$34.15M(+11.6%)
-$3.22M(-47.1%)
-$18.76M(+25.9%)
Sep 2002
-
-$2.19M(+69.5%)
-$25.32M(+20.2%)
Jun 2002
-
-$7.17M(-15.7%)
-$31.74M(+6.2%)
Mar 2002
-
-$6.19M(+36.7%)
-$33.85M(+12.4%)
Dec 2001
-$38.64M(-27.5%)
-$9.78M(-13.5%)
-$38.64M(-35.5%)
Sep 2001
-
-$8.61M(+7.1%)
-$28.51M(+2.1%)
Jun 2001
-
-$9.27M(+15.7%)
-$29.13M(-39.1%)
Mar 2001
-
-$10.99M(-3195.5%)
-$20.93M(+1.9%)
Dec 2000
-$30.31M(-276.9%)
$355.00K(+103.8%)
-$21.34M(+1.6%)
Sep 2000
-
-$9.22M(-758.1%)
-$21.70M(-74.0%)
Jun 2000
-
-$1.07M(+90.6%)
-$12.47M(+4.5%)
Mar 2000
-
-$11.40M(-587.9%)
-$13.05M(-305.7%)
Dec 1999
-$8.04M
-
-
Jun 1999
-
-$1.66M(-6.1%)
-$3.22M(-106.1%)
Mar 1999
-
-$1.56M
-$1.56M

FAQ

  • What is Insmed Incorporated annual EBITDA?
  • What is the all-time high annual EBITDA for Insmed Incorporated?
  • What is Insmed Incorporated annual EBITDA year-on-year change?
  • What is Insmed Incorporated quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Insmed Incorporated?
  • What is Insmed Incorporated quarterly EBITDA year-on-year change?
  • What is Insmed Incorporated TTM EBITDA?
  • What is the all-time high TTM EBITDA for Insmed Incorporated?
  • What is Insmed Incorporated TTM EBITDA year-on-year change?

What is Insmed Incorporated annual EBITDA?

The current annual EBITDA of INSM is -$818.79M

What is the all-time high annual EBITDA for Insmed Incorporated?

Insmed Incorporated all-time high annual EBITDA is $120.31M

What is Insmed Incorporated annual EBITDA year-on-year change?

Over the past year, INSM annual EBITDA has changed by -$158.62M (-24.03%)

What is Insmed Incorporated quarterly EBITDA?

The current quarterly EBITDA of INSM is -$257.36M

What is the all-time high quarterly EBITDA for Insmed Incorporated?

Insmed Incorporated all-time high quarterly EBITDA is $389.00K

What is Insmed Incorporated quarterly EBITDA year-on-year change?

Over the past year, INSM quarterly EBITDA has changed by -$61.33M (-31.29%)

What is Insmed Incorporated TTM EBITDA?

The current TTM EBITDA of INSM is -$976.65M

What is the all-time high TTM EBITDA for Insmed Incorporated?

Insmed Incorporated all-time high TTM EBITDA is -$1.35M

What is Insmed Incorporated TTM EBITDA year-on-year change?

Over the past year, INSM TTM EBITDA has changed by -$283.73M (-40.95%)
On this page